Get started
Author

Clare Proudfoot

Observed names: C Proudfoot, C. Proudfoot, C.J. Proudfoot, Clare J. Proudfoot, Clare W J Proudfoot, Clare W Proudfoot, Clare W. J. Proudfoot, Clare Winifred Jane Proudfoot, Proudfoot C, Proudfoot, Clare
Observed institutions: Novartis (Switzerland), Sorbonne Université, Assistance Publique – Hôpitaux de Paris, ViiV Healthcare (United Kingdom), Sanofi (United States), Pitié-Salpêtrière Hospital, Institut Pierre Louis d‘Épidémiologie et de Santé Publique, Stanford Medicine, Sanofi (United Kingdom), Université Pierre-et-Marie-Curie, Stanford University, University of Edinburgh
OpenAlex ID: A5029781530
Analgesia Mediated by the TRPM8 Cold Receptor in Chronic Neuropathic Pain
2006 · Clare J. Proudfoot, Emer M. Garry, et al. · Current Biology · 417
PDF
A systematic review of the impact of sedation practice in the ICU on resource use, costs and patient safety
2010 · Daniel L Jackson, Clare W Proudfoot, et al. · Critical Care · 165
PDF
The incidence of sub-optimal sedation in the ICU: a systematic review
2009 · Daniel L Jackson, Clare W Proudfoot, et al. · Critical Care · 141
PDF
Recurrent Heart Failure Hospitalizations are Associated with Increased Cardiovascular Mortality in Patients with Heart Failure in Clinical Practice Research Datalink
2020 · Raquel Lahoz, Ailís Fagan, et al. · ESC Heart Failure · 67
PDF
Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review
2021 · Clare Proudfoot, Rachel Studer, et al. · International Journal of Cardiology · 55
PDF
Caregivers of Patients with Heart Failure: Burden and the Determinants of Health-Related Quality of Life
2021 · Raquel Lahoz, Clare Proudfoot, et al. · Patient Preference and Adherence · 52
PDF
Recurrent Hospitalizations are Associated with Increased Mortality Across the Ejection Fraction Range in Heart Failure
2020 · Jenni Huusko*, Samuli Tuominen, et al. · ESC Heart Failure · 48
PDF
Patient-reported outcomes from a randomized phase III trial of sarilumab monotherapy versus adalimumab monotherapy in patients with rheumatoid arthritis
2018 · Vibeke Strand, Laure Gossec, et al. · Arthritis Research & Therapy · 45
PDF
Sarilumab improves patient-reported outcomes in rheumatoid arthritis patients with inadequate response/intolerance to tumour necrosis factor inhibitors
2017 · Vibeke Strand, Matthew Reaney, et al. · RMD Open · 43
PDF
Recurrent Heart Failure Hospitalizations Increase the Risk of Cardiovascular and All-Cause Mortality in Patients with Heart Failure in Sweden: A Real-World Study
2021 · Krister Lindmark, Kurt Boman, et al. · ESC Heart Failure · 41
PDF
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis Changing Biologics in the USA
2017 · Benjamin Chastek, Chieh-I Chen, et al. · Advances in Therapy · 38
PDF
Burden and Quality of Life Among Female and Male Patients with Heart Failure in Europe: A Real-World Cross-Sectional Study
2021 · Ana Filipa Fonseca, Raquel Lahoz, et al. · Patient Preference and Adherence · 33
PDF
Evaluation of the efficacy and safety of sarilumab combination therapy in patients with rheumatoid arthritis with inadequate response to conventional disease-modifying antirheumatic drugs or tumour necrosis factor α inhibitors: systematic literature review and network meta-analyses
2019 · Ernest Choy, Nick Freemantle, et al. · RMD Open · 27
PDF
Quantifying association of early proteinuria and estimated glomerular filtration rate changes with long-term kidney failure in C3 glomerulopathy and immune-complex membranoproliferative glomerulonephritis using the United Kingdom RaDaR Registry
2025 · Sherry Masoud, Katie Wong, et al. · Kidney International · 26
PDF
Treatment Persistence and Healthcare Costs Among Patients with Rheumatoid Arthritis After a Change in Targeted Therapy.
2018 · Machaon M K Bonafede, Donna McMorrow, et al. · Europe PMC (PubMed Central) · 18
Effects of Sarilumab on Rheumatoid Arthritis as Reported by Patients Using the Rheumatoid Arthritis Impact of Disease Scale
2019 · Laure Gossec, Vibeke Strand, et al. · The Journal of Rheumatology · 15
PDF
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs
2019 · Noemi Muszbek, Clare Proudfoot, et al. · Advances in Therapy · 13
PDF
Hospitalization Rates in Patients with Heart Failure and Reduced Ejection Fraction Initiating Sacubitril/Valsartan or Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers: A Retrospective Cohort Study
2022 · Emma Houchen, Emil Loefroth, et al. · Cardiology and Therapy · 12
PDF
Model parameters influencing the cost-effectiveness of sacubitril/valsartan in heart failure: evidence from a systematic literature review
2022 · Clare Proudfoot, Raju Gautam, et al. · The European Journal of Health Economics · 9
PDF
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively treated patient
2019 · Marie Fournier, Chieh-I Chen, et al. · ClinicoEconomics and Outcomes Research · 9
PDF
Recurrent heart failure hospitalizations increase the risk of mortality in heart failure patients with atrial fibrillation and type 2 diabetes mellitus in the United Kingdom: a retrospective analysis of Clinical Practice Research Datalink database
2022 · Raquel Lahoz, Ailís Fagan, et al. · BMC Cardiovascular Disorders · 8
PDF
A UK-wide analysis of 2265 patients receiving a reversal agent for direct oral anticoagulant–associated bleeding
2025 · Richard J. Buka, Michala Pettitt, et al. · Journal of Thrombosis and Haemostasis · 7
PDF
Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
2019 · Ernest Choy, Nick Freemantle, et al. · Advances in Therapy · 6
PDF
Treatment and Disease Burden in Patients with Complement 3 Glomerulopathy: Multinational Real-World Study Results
2025 · Smeeta Sinha, Jonathan de Courcy, et al. · Glomerular Diseases · 4
PDF
#2632 Quality of life and fatigue burden in individuals living with Complement 3 Glomerulopathy – a real-world study
2024 · Richard Lafayette, Raisa Sidhu, et al. · Nephrology Dialysis Transplantation · 4
Works count: 80
Citation count: 1,335
H-index: 15
I10-index: 18
Year
Topic
Type